News for 'Institute of Clinical Research'

Covid vaccine possible by 2021 first quarter: Vardhan

Covid vaccine possible by 2021 first quarter: Vardhan

Rediff.com13 Sep 2020

Vardhan stated the government is taking full precautions in human trials of vaccines and the National Expert Group on Vaccine Administration for COVID-19 under the chairmanship of Dr V K Paul, member-health, NITI Aayog, is drawing up a detailed strategy on how to immunize the majority of the population.

'Safety, efficacy main concerns with Russia's COVID-19 vaccine'

'Safety, efficacy main concerns with Russia's COVID-19 vaccine'

Rediff.com17 Aug 2020

Nobel laureate Peter Doherty says his 'big worry' is there could be refusals for other vaccines if doubts over its safety turn out to be true.

Bharat Biotech's Krishna Ella wins Covaxin fight

Bharat Biotech's Krishna Ella wins Covaxin fight

Rediff.com22 Mar 2021

'He came back from the US only to work for his country.' 'He has invested his fortunes to build this company and is married to his work.' 'Rarely does one see such commitment.'

Covid vaccine participant alleges side effects, seeks Rs 5 cr from Serum

Covid vaccine participant alleges side effects, seeks Rs 5 cr from Serum

Rediff.com29 Nov 2020

Alleging that the candidate vaccine was not safe, he has also sought cancelling approval for its testing, 'manufacture and distribution', failing which legal action would be taken.

Next 2.5 months crucial in fight against Covid: Vardhan

Next 2.5 months crucial in fight against Covid: Vardhan

Rediff.com16 Oct 2020

He expressed hope that India will soon have indigenous production of vaccine against coronavirus.

Coronavirus may have mutated, potentially evolving: Study

Coronavirus may have mutated, potentially evolving: Study

Rediff.com24 Sep 2020

'Wearing masks, washing our hands, all those things are barriers to transmissibility, or contagion, but as the virus becomes more contagious it statistically is better at getting around those barriers'

For India's cannabis industry the grass could be greener

For India's cannabis industry the grass could be greener

Rediff.com9 Mar 2021

'The government wants farmers to diversify from rice and wheat, and create another green revolution. Cannabis can play a big part in that'

Scientists sceptical about Russia's COVID-19 vaccine

Scientists sceptical about Russia's COVID-19 vaccine

Rediff.com12 Aug 2020

Scientists around the world, including in India, suggest it hasn't been tested properly given the time constraint and there may not be enough evidence to prove its efficacy.

MPs will need COVID negative report for Parliament

MPs will need COVID negative report for Parliament

Rediff.com4 Sep 2020

The COVID-19 test of the MPs need to be done 72 hours before the start of the session and it can be done either in their constituencies or at the Parliament complex.

Covid vax safe for cancer patients, causes no side-effects: Study

Covid vax safe for cancer patients, causes no side-effects: Study

Rediff.com21 Sep 2021

People with cancer have an appropriate, protective immune response to COVID-19 vaccines without experiencing any more side-effects than the general population, researchers said on Tuesday.

Govt allows round-the-clock vaccination against COVID-19

Govt allows round-the-clock vaccination against COVID-19

Rediff.com4 Mar 2021

Easing restrictions, all private hospitals were on Tuesday allowed to give the vaccines if they adhere to the laid down norms, while the 9 am to 5 pm timing was also done away with.

30 groups in India trying to develop COVID-19 vaccine: PSA

30 groups in India trying to develop COVID-19 vaccine: PSA

Rediff.com28 May 2020

Without naming the entity, he said some players are at a pre-clinical stage and may reach the clinical stage by October. Responding to a question on absence of a vaccine currently and the prospects in the next few months as the lockdown eases, VijayRaghvan emphasised on aggressive rapid testing and tracking.

First COVID-19 vaccine human trial finds it's safe

First COVID-19 vaccine human trial finds it's safe

Rediff.com23 May 2020

The first COVID-19 vaccine to reach phase I clinical trial is safe, well-tolerated, and capable of generating an immune response against the novel coronavirus in humans, says a new research published in The Lancet journal.

DRDO's 1st batch of anti-Covid drug 2DG launched

DRDO's 1st batch of anti-Covid drug 2DG launched

Rediff.com17 May 2021

The drug comes in powder form in a sachet, which is taken orally by dissolving it in water. It accumulates in the virus-infected cells and prevents virus growth by stopping viral synthesis and energy production.

How sitting for longs hours affects your brain

How sitting for longs hours affects your brain

Rediff.com15 Apr 2018

It may even increase the risk of dementia, says study.

After Odisha, Punjab extends lockdown till May 1

After Odisha, Punjab extends lockdown till May 1

Rediff.com11 Apr 2020

Amarinder said predictions by health experts about the spread of the pandemic are 'horrendous and frightening'.

Govt extends gap between 2 doses of Covishield to 12-18 weeks

Govt extends gap between 2 doses of Covishield to 12-18 weeks

Rediff.com13 May 2021

The NTAGI has also stated that those having laboratory test proven SARS-CoV-2 illness should defer COVID-19 vaccination for six months after recovery, the sources said.

Never spoke about vaccinating entire country: Govt

Never spoke about vaccinating entire country: Govt

Rediff.com2 Dec 2020

Indian Council of Medical Research Director General Balram Bhargava said the purpose of the COVID vaccine drive would be to break the chain of viral transmission.

Phase II trial finds Chinese COVID-19 vaccine is safe

Phase II trial finds Chinese COVID-19 vaccine is safe

Rediff.com21 Jul 2020

Since the trial participants were not exposed to the coronavirus after vaccination, the scientists said it is not possible for the current study to determine the efficacy of the candidate vaccine.

Painkiller discovered in human body: Report

Painkiller discovered in human body: Report

Rediff.com15 Nov 2006

A new painkilling substance, produced naturally by the human body, has been discovered to be up to six times more potent than morphine when tested on rats, researchers said.

Newton, Darwin take note: Gagandeep Kang makes history

Newton, Darwin take note: Gagandeep Kang makes history

Rediff.com8 May 2019

Women are great team players and collaborators, 'but they don't put themselves forward,' Dr Gagandeep Kang, the first Indian woman scientist to be elected as a Fellow of the Royal Society, tells Veenu Sandhu.

India's COVID-19 tally crosses 18-lakh mark

India's COVID-19 tally crosses 18-lakh mark

Rediff.com3 Aug 2020

This is the fifth consecutive day that COVID-19 cases have increased by more than 50,000 in the country.

India's children may get 2 Covid vaccines by December

India's children may get 2 Covid vaccines by December

Rediff.com28 Jun 2021

While Bharat Biotech's Covaxin is in trials among children already, Serum Institute of India will begin Novavax vaccine trials on children from July, whereas the Pfizer vaccine has been approved for adolescents in the United States; and Cadila Healthcare's ZyCoV-D has done trials on 12 year-olds and above already, reports Sohini Das.

How this start-up saves lives

How this start-up saves lives

Rediff.com25 Apr 2016

The company has been developing donor-derived stem cell platforms.

Lost your sense of smell, taste? It may be COVID-19

Lost your sense of smell, taste? It may be COVID-19

Rediff.com14 Apr 2020

According to a study, published in the journal International Forum of Allergy and Rhinology, people with influenza-like symptoms, and a dysfunction of smell and taste, are strongly associated with COVID-19 infection.

Bharat Biotech plans to supply 90 million Covaxin doses a month by Dec

Bharat Biotech plans to supply 90 million Covaxin doses a month by Dec

Rediff.com30 Sep 2021

In September, Bharat Biotech aimed to supply 35 million doses, and take this up to 55 million by October. This is still less than what the Indian government expects from the company.

'Vaccine is far safer than getting Covid'

'Vaccine is far safer than getting Covid'

Rediff.com16 Jan 2021

'I would go for Bharat Biotech's Covaxin and not Covishield, and that is my personal judgment since at least 11,500 have got at least one dose by now and it has proven to be safe.'

PM announces health IDs for all under new mission

PM announces health IDs for all under new mission

Rediff.com15 Aug 2020

The health ID will contain information about medical data, prescriptions and diagnostic reports and summaries of previous discharge from hospitals for ailments. The mission is expected to bring efficiency and transparency in healthcare services in the country.

In a first, Australian doctors transplant dead heart

In a first, Australian doctors transplant dead heart

Rediff.com24 Oct 2014

Scientists have made a dead heart beat again and successfully transplanted it in world's first ever game changing surgery.

COVID-19: Remdesivir will be available from next week

COVID-19: Remdesivir will be available from next week

Rediff.com4 May 2020

The EUA allows for Remdesivir to be distributed in the US and administered intravenously by health care providers, as appropriate, to treat suspected or laboratory-confirmed COVID-19 in adults and children hospitalised with severe condition.

50% of all pregnancies in India unintended

50% of all pregnancies in India unintended

Rediff.com21 Dec 2017

According to a Lancet study an estimated 15.6 million abortions took place in India in 2015, of which about half of the pregnancies were unintended.

COVID-19: 'We will be dealing with it for 2 years at least'

COVID-19: 'We will be dealing with it for 2 years at least'

Rediff.com29 Oct 2020

'The most intriguing thing (about COVID-19) is the range of the illness -- from asymptomatic or less symptoms to death and quite severe manifestations.' 'The vaccine will be at least another year away from having any effect.'

Geneticist Raj Barathur passes into the ages

Geneticist Raj Barathur passes into the ages

Rediff.com27 Aug 2020

Raj Barathur -- Indian American entrepreneur, geneticist, professor and biopharmaceutical industry leader -- stayed the course even when diagnosed with lung cancer

The maverick who changed India's legal education

The maverick who changed India's legal education

Rediff.com10 Feb 2020

Whenever the history of India's National Law Schools is written, N R Madhava Menon's name will be deeply inscribed in it, says Mohammad Zeeshan Ahmad.

Enough stockpile of COVID-19 vaccine for priority groups: Niti member

Enough stockpile of COVID-19 vaccine for priority groups: Niti member

Rediff.com4 Jan 2021

Paul noted that "three to four months from now, there will be other vaccines and the stockpile will be even bigger. "And more acceleration can be brought about in the vaccination programme," Paul added.

Budget: A vision for priority areas

Budget: A vision for priority areas

Rediff.com1 Mar 2007

It is a Budget with a strong emphasis on agriculture, education, healthcare and infrastructure.

At current rate, all Indians will be vaccinated by Sept 2022

At current rate, all Indians will be vaccinated by Sept 2022

Rediff.com28 Jun 2021

865 million Indian adults require vaccination.

Good night's sleep = better math performance

Good night's sleep = better math performance

Rediff.com10 Jan 2015

Parents, take note! Schoolchildren who get a good night's sleep perform better in math and languages, a new study has found.

Shortage of key chemical from US hits Covaxin ramp-up plans

Shortage of key chemical from US hits Covaxin ramp-up plans

Rediff.com22 Apr 2021

'In case of shortage of other raw material, like filters and bags, one can try to develop another vendor. However, for chemicals as critical as adjuvants, this is not possible'